Latest news
Tempus AI (TEM) After CellCarta Deal And PRISM2 Validation Faces A Fresh Valuation Test - simplywall.stsimplywall.st · Sun, 09 Aug 2026 16:33:44 GMTWhy Tempus AI (TEM) Is Up 18.6% After Joining CellCarta’s CDx Commercialization Lab Network - simplywall.stsimplywall.st · Sat, 08 Aug 2026 12:48:29 GMT